Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
$101,332 to $113,918 Fixed term (2.5 years), Full-time, Joondalup Campus Open to candidates with relevant work rights POST DOCTORAL RESEARCH FELLOW (ARTIFICIAL INTELLIGENCE) COMPUTING AND SECURITY
-
ANSTO (Australia), Imperial College London (UK), and Tokamak Energy (UK), is launching a groundbreaking research program focused on developing new materials for compact tokamak reactors. We are recruiting
-
prevention. The successful candidate will join the Wildlife Crime Research Hub and work as part of the ARC Industry Laureate Fellowship program, Combatting Wildlife Crime and Preventing Environmental Harm
-
Doctoral Scientist position. This position will report to Professor Jose Polo, Lead of the Cancer Epigenetics Program at the South Australian Immunogenomics Cancer Institute (SAiGENCI) and the Inaugural
-
Premier’s Science Fellowship Program, the Population Biology and Genomics Group is a new and rapidly growing research group in the School of Molecular and Life Sciences at Curtin University. To find out more
-
your personal circumstances. ECU has an Award-winning Health and Wellness Program and an extensive range of staff benefits across entertainment, financial, health, travel and consumer goods and services
-
CEPAR’s Asia program. Conduct research independently or as part of a team. Build and use models, software, and databases; analyse data and share findings. Help prepare funding applications with guidance
-
Employee Assistance Program for staff and their immediate family UQ Study for Staff On campus childcare options Affordable parking (from just $6.15 a day) Salary packaging options About You Diploma in
-
. To be successful in this position, you’ll have: PhD (or equivalent) in computational and/or theoretical chemistry or will complete a PhD in this field within the next six months. Experience in
-
fundamental research and the pharmaceutical and biotechnology industries. The research program is co-funded by the Australian Research Council and the Sydney- and US-based biotech company INSAMO and the